Vice President Clinical Development Arcellx, Inc.Seattle, Washington
Disclosure information not submitted.
Anitocabtagene Autoleucel: Innovation in BCMA-Targeting Therapeutics
Saturday, September 20, 202510:25 - 10:33 East Coast USA Time